Author: Roboticulized.com

finvolution-maintains-status-of-low-risk-rating-from-sustainalytics

FinVolution maintains status of Low-Risk Rating from Sustainalytics

December 6, 2022 Published by

 

FinVolution Group (“FinVolution,” or the “Company”) (NYSE: FINV), a leading fintech platform, today announced that it has received a “low risk” Environmental, Social and Governance (ESG) rating from Sustainalytics for the second consecutive year, placing the Company’s ESG performance among the top 15% of its industry peer group.

Sustainalytics’ ESG Risk Ratings measure the degree to which a company’s economic value is at risk driven by ESG factors or, in other words, the magnitude of a company’s unmanaged ESG risks. Covering more than 16,000 companies, Sustainalytics provides the widest coverage of analyst-based ESG Risk Ratings in the market. Based on scoring across a broad range of categories and metrics, FinVolution was designated as “low risk” by Sustainalytics’ ESG Risk Rating system.

Mr. TieZheng Li, Deputy Chairman and President of FinVolution, commented, “We are very proud that our ESG efforts are recognized by Sustainalytics once again this year, a compelling testament to our visions, policies and practices of sustainability. Committed as always, we strive to promote all aspects of ESG in our operations, including corporate governance and behavior, data privacy and security, human capital development, environmental protection and corporate social responsibility. Moving forward, we will continue to enhance our ESG engagement, redoubling our efforts to propel sustainable development while also creating long-term value for our stakeholders.”

paint-thinner-market-to-garner-$164-billion,-globally,-by-2031-at-4.1%-cagr,-says-allied-market-research

Paint Thinner Market to Garner $16.4 Billion, Globally, By 2031 at 4.1% CAGR, Says Allied Market Research

December 6, 2022 Published by

 

Allied Market Research published a report, titled, “Paint Thinner Market by Solvent Type (Acetone, Turpentine, Naphtha, Toluene, Methyl Ethyl Ketone, Others), by Application (Paints and Coatings, Industrial Equipment, Others): Global Opportunity Analysis and Industry Forecast, 2021-2031“. According to the report, the global paint thinner industry was estimated at $11.0 billion in 2021, and is anticipated to hit $16.4 billion by 2031, registering a CAGR of 4.1% from 2022 to 2031. The report offers an explicit analysis of the changing market trends, top segments, key investment pockets, value chains, competitive scenarios, and regional landscapes.

Request PDF Brochure: https://www.alliedmarketresearch.com/request-sample/32094

Determinants of growth:

Growing population base has led to rapid urbanization in both developed and developing economies such as the U.S., China, India has increased government expenditure on the building & construction sector to develop various infrastructure projects, which in turn has driven the paint thinner market. On the other hand, the cost involved in the formulation of paint thinners is high that results in expensive final products, which impedes the growth to some extent. However, rise in young population coupled with increase in number of car enthusiasts have created lucrative opportunities in the industry.

Covid-19 scenario:

  • Dependence of the paint thinner market on industries such as aerospace, building & construction, and automotive & transportation had a sheer negative impact on the market growth.
  • However, rise in awareness about using eco-friendly products among citizens of both developed and developing economies has increased the popularity of paint thinners with minimal or no volatile organic compounds (VOCs) emissions in various end use sectors post Covid-19.

The methyl ethyl ketone segment garnered the highest share:

By solvent type, the methyl ethyl ketone segment held the major share in 2021, generating nearly one-third of the global paint thinner market revenue. The same segment would also showcase the fastest CAGR of 4.6% during the forecast period. This is due to the fact that increasing demand for consumer goods has increased the establishment of chemical manufacturing units in both developed and developing economies where methyl ethyl ketone-based paint thinners are extensively used along with paints for finish coat in steel structures, industrial equipment, and others.

Enquire for Customization with Detailed Analysis of COVID-19 Impact in Report @ https://www.alliedmarketresearch.com/request-for-customization/32094

The paints and coatings segment garnered the major share in 2021:

By application, the paints and coatings segment generated the highest share in 2021, garnering nearly two-thirds of the global paint thinner market revenue and is expected to rule the roost by 2031. The same segment would also portray the fastest CAGR of 4.3% during the forecast period. This is attributed to the increasing population coupled with rapid urbanization, which in turn have surged the demand for both residential and commercial facilities where a wide range of paint thinners are used in conjunction with paints & coatings to enhance the visual appeal, surface durability, chemical protection and pest protection.

Asia-Pacific grabbed the lion’s share:

By region, the Asia-Pacific region contributed to nearly half of the global paint thinner market revenue in 2021, and is projected to rule the roost by 2031. The same region would also showcase the fastest CAGR of 4.4% from 2022 to 2031. This is attributed to the huge advancements made in industries such as building & construction, transportation, industrial, and others across the region.

Key players in the industry:

  • Hempel A/S
  • Jotun
  • Kansai Paint Co., Ltd.
  • Kwality Paints and Coatings Pvt. Ltd.
  • PPG Industries, Inc.
  • RPM International Inc.
  • The Sherwin-Williams Company
  • Axalta Coating Systems, LLC
  • Zigma Paints Pvt. Ltd.

The report analyzes these key players in the global paint thinner market. These players have incorporated various strategies such as expansion, new product launches, partnerships, and others to increase their market penetration and strengthen their position in the industry. The report is helpful in assessing the operating segments, their business performance & product portfolio, and so on.

Want to Access the Statistical Data and Graphs, Key Players’ Strategies:
https://www.alliedmarketresearch.com/paint-thinner-market/purchase-options

Similar Reports:

Antifouling Paints and Coatings Market: Global Opportunity Analysis and Industry Forecast, 2021-2031

Paints and Coatings Market: Global Opportunity Analysis and Industry Forecast, 2021-2031

Mosquito-Repellent Paints Market: Global Opportunity Analysis and Industry Forecast, 2021-2030

Egypt Paints & Coatings Market: Opportunity Analysis and Industry Forecast, 2020-2027

Mineral Turpentine Market: Global Opportunity Analysis and Industry Forecast, 2021-2031

Toluene Market: Global Opportunity Analysis and Industry Forecast, 2021-2030

disqo-welcomes-salesforce-veteran-scott-henderson-as-cfo

DISQO WELCOMES SALESFORCE VETERAN SCOTT HENDERSON AS CFO

December 6, 2022 Published by

 

Customer experience (CX) intelligence platform DISQO™ today announced Scott Henderson as its new Chief Financial Officer. Reporting to co-founder and CEO Armen Adjemian, Henderson now leads DISQO’s finance organization, along with revenue operations, sales enablement and business systems. He’ll develop financial strategies for the company’s continued growth, with a focus on efficiency and the alignment of teams and technologies.

Henderson joins DISQO following 20+ years at Salesforce in roles spanning revenue operations, financial planning/analysis, and controllership, including 7 years building out and leading the EMEA and International Finance function. As EVP of Global Revenue Operations, he led financial strategy and oversaw a team of over 600 employees in 13 countries. He joined Salesforce as an early startup in 2002, and played a pivotal role growing the company into the global enterprise of 75,000+ employees that it is today.

“Scott’s financial management experience in tech at Salesforce, combined with his impressive track record scaling companies into global enterprises, makes him the ideal person for DISQO,” said Adjemian. “As more brands turn to DISQO to power data-driven decision making with their customers at the center, Scott will be instrumental in capitalizing on our growth opportunities to deliver more value for our customers and stakeholders.”

In addition to his time at Salesforce, Henderson has held a series of leadership roles at other high-growth startups and global companies like Apple, Hexcel Corporation and APL. He has an impeccable reputation as a growth-driving finance executive adept at building strategies that have scaled companies from $25 million to $30 billion in revenue.

“In today’s environment, as companies look for more efficiency and uplift from all of their customer decisions and touchpoints, DISQO is well positioned to thrive beyond the current macroeconomic challenges,” said Henderson. “I look forward to working with the team and the Board to amplify DISQO’s impact in the CX space, and to help shape and scale the company for the future.”

DISQO has had a banner year bringing in innovative leaders to help sharpen its offerings and scale the business. Leadership appointments this year include: Nicholas Weaver, Vice President of Engineering, Andrew Duke, VP of Product, Consumer Applications, and David Squellati, General Counsel. For a full list of open roles, visit disqo.com/careers.

ineo-announces-investor-webinar-for-fiscal-2023-first-quarter-financial-results-and-corporate-update

INEO Announces Investor Webinar for Fiscal 2023 First Quarter Financial Results and Corporate Update

December 5, 2022 Published by

 

INEO Tech Corp. (TSXV: INEO) (OTCQB: INEOF) (the “Company” or “INEO“), the innovative developer and operator of the INEO Media Network, a digital advertising and analytics solution for retailers, is pleased to hold an investor webinar on Wednesday, December 7, 2022 at 10:00 am PT (1:00 pm ET). The call will be hosted by: Kyle Hall, Chief Executive Officer; Greg Watkin, Chairman and President, and Pardeep S. Sangha, Head of Investor Relations.

During the webinar INEO’s management will discuss the Company’s recently announced fiscal 2023 first quarter results, as well as provide an update on its customer deployments with large retailers and comment on the Company’s future outlook. Despite the current challenging macroeconomic environment INEO has not experienced any recessionary impacts and the Company reported 74% year-over-year increase in revenue for its fiscal 2023 first quarter ended September 30, 2022. The overall outlook for INEO remains positive with the Company actively deploying systems and ramping up its installation locations with contracted customers.

mobile-wallet-market-to-hit-$5153-billion-by-2030:-grand-view-research,-inc.

Mobile Wallet Market to Hit $51.53 Billion by 2030: Grand View Research, Inc.

December 5, 2022 Published by

 

The global mobile wallet market size is expected to reach USD 51.53 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 27.4% from 2022 to 2030. A mobile wallet is a technology that can carry cash in digital format. Increasing mobile phone users and the rising number of internet subscribers across the world are the major factors fueling the market growth. In addition, government initiatives to modernize the transportation sector are improving market growth.

Key Industry Insights & Findings from the report:

  • In terms of technology, the proximity segment accounted for the largest revenue share of over 60.0% in 2021 and is expected to retain its dominance over the forecast period. Growing penetration of NFC and QR code-enabled smartphones across the world is boosting the segment growth.
  • The remote segment is anticipated to expand at the highest CAGR of 27.7% over the forecast period. The growth of this segment can be attributed to the increasing number of smartphone and internet users across the globe. In addition, surging demand for fast and secure payment solutions is improving the market growth.
  • In terms of application, the retail and e-commerce segment accounted for the largest revenue share of over 30.0% in 2021 and is expected to retain its dominance over the forecast period. Rapid growth in the global retail and e-commerce sector is creating more demand for mobile wallets.
  • The banking segment is expected to register the highest CAGR of 28.7% during the forecast period as numerous banks across the world are trying to set up mobile payments.
  • The hospitality and transportation segment is expected to witness significant growth over the forecast period. Due to ongoing concerns about sanitation and a desire to reduce contact between guests and staff members, mobile wallets are anticipated to create a notable impact on the hospitality or restaurant industry.

Read full market research report for more Insights, “Mobile Wallet Market Size, Share & Trends Analysis Report By Technology (Remote, Proximity), By Application (Retail & E-commerce, Banking, Hospitality & Transportation), By Region, And Segment Forecasts, 2022 – 2030“, published by Grand View Research.

Mobile Wallet Market Growth & Trends

Furthermore, due to ongoing concerns about sanitation and a desire to reduce contact between guests and staff members, mobile wallets are anticipated to create a notable impact on the hospitality or restaurant industry. Furthermore, COVID-19 has increased the penetration of online payments. The pandemic has increased the requirement for germ-free and contactless payments, and mobile wallets prevent direct contact with any external system such as the POS of the retailer.

Asia Pacific held the largest revenue share of over 30.0% in 2021 and is expected to retain its position over the forecast period. In rapidly developing regions such as Asia Pacific, digital online spending has changed and evolved on its own, with e-commerce expanding and online sales becoming as common as physical retail in many areas of the region. In April 2022, Boku, a global provider of mobile payment solutions, announced that its Mobile First (M1ST) platform has unveiled PayPay mobile wallet payments for Netflix in Japan. With this release, PayPay’s over 45 million consumers can now pay for streaming subscriptions within Netflix.

Mobile Wallet Market Segmentation

Grand View Research has segmented the global mobile wallet market based on technology, application, and region

Mobile Wallet Market – Technology Outlook (Revenue, USD Million, 2017 – 2030)

  • Remote
  • Proximity

Mobile Wallet Market – Application Outlook (Revenue, USD Million, 2017 – 2030)

  • Retail & E-commerce
  • Hospitality & Transportation
  • Banking
  • Vending Machine
  • Others

Mobile Wallet Market – Regional Outlook (Revenue, USD Million, 2017 – 2030)

  • North America
    • o U.S.
    • o Canada
  • Europe
    • o U.K.
    • o Germany
    • o Rest of Europe
  •  Asia Pacific
    • o China
    • o India
    • o Japan
    • o Rest of Asia Pacific
  • Latin America
    • o Brazil
    • o Mexico
    • o Rest of Latin America
  • Middle East & Africa

List of Key Players in Mobile Wallet Market

  • Amazon Web Services Inc.
  • Visa Inc.
  • American Express
  • PayPal Holdings Inc.
  • Apple Inc.
  • Google Inc.
  • Airtel India
  • Mastercard
  • Alipay
  • Samsung
  • AT&T

Check out more related studies published by Grand View Research:

  • Retail E-Commerce Market – The global retail e-commerce market size is expected to reach USD 8.6 trillion by 2027, according to a new report by Grand View Research, Inc. It is projected to expand at a CAGR of 9.4% over the forecast period. The availability of the product online at low price as compared to physical stores owing to direct sale from the manufacturer without the intervention of any third-party seller is anticipated to fuel the growth. Moreover, discounts and bundling offer to propel product sales and attract huge consumers group towards online shopping has increase the popularity of retail e-commerce. The other factor expected to drive the online purchase is cash-on-delivery facility provided by the online retailers.
  • Digital Rights Management in Media & Entertainment Market – The global digital rights management in media & entertainment market is expected to reach USD 6.12 billion by 2028, expanding at a CAGR of 16.5% from 2021 to 2028, according to the new study conducted by Grand View Research, Inc. Rapid growth in digital media and internet connectivity globally have created immense opportunities for content publishers and content distribution partners to grow their creative media content. However, with the boost in digital technologies, digital piracy and illegal distribution of content have significantly increased, negatively affecting the monetization opportunities for content distributors and content owners. These challenges are compelling content owners to seek and exercise control over the unauthorized access and distribution of content.
  • Pay TV Market – The global pay TV market size is anticipated to reach USD 265.44 billion by 2028, exhibiting a CAGR of 1.7% over the forecast period, according to a new report by Grand View Research, Inc. Rising competition from OTT media providers is promoting pay TV operators to disrupt existing business models and strategize more efficient profit generation methodologies. Additionally, emerging players, such as MOBITV, offer customized, cost-effective, and flexible options to their customers according to their demands, thus ensuring customer satisfaction. This is expected to promote new and existing players to diversify their existing service offerings and ensure healthy competition in the market.

Browse through Grand View Research’s Digital Media Industry Research Reports.

quantiphi-awarded-two-2022-regional-and-global-aws-partner-awards

Quantiphi Awarded Two 2022 Regional and Global AWS Partner Awards

November 29, 2022 Published by

 

Quantiphi, an artificial intelligence (AI)-first digital engineering company and AWS Premier Tier Services Partner in the Amazon Web Services (AWS) Partner Network (APN), is excited to announce it is a recipient of two 2022 Regional and Global AWS Partner Awards, Machine Learning/Artificial Intelligence (ML/AI) Partner of the Year in North America and Industry Partner of the Year in North America.

Announced during a Partner Awards Gala at AWS re: Invent 2022, the Regional and Global AWS Partner Awards recognize a wide range of AWS Partners whose business models have embraced specialization, innovation, and cooperation over the past year. Regional and Global Partner Awards recognize partners whose business models continue to evolve and thrive on AWS as they work with customers.

Already an AWS Premier-tier Partner with the AWS Machine Learning Competency, Quantiphi developed a serverless and scalable machine learning operations platform NeuralOps (MLOps), for its customers. Powered by Amazon SageMaker, the platform created high-quality data attributes and audience propensities at scale.

Quantiphi also helped one of the United States’ largest supplemental insurance companies streamline their rule-based and document-heavy processes by automating claims adjudication. It simplified the process of submitting insurance claims and tracking them, minimizing iterations in the proof of loss documentation.

“Quantiphi is honored to have earned not one, but two Regional and Global AWS Partner Awards this year – the Machine Learning/Artificial Intelligence (ML/AI) Partner of the Year in North America and Industry Partner of the Year in North America,” said Jim Keller, AWS Channel Global Leader at Quantiphi. “These strategic awards demonstrate Quantiphi as a compelling and unique AWS Partner for ML/AI and FinServ categories. They also showcase our experience deploying customer solutions on AWS and helping customers realize transformational opportunities through our deep domain knowledge. ”

For the first time, the Regional and Global AWS Partner Awards included a self-nomination process across several award categories and specialization areas awarded at regional and global levels, where all AWS Partners were invited to participate and submit a nomination.

The AWS Partner Network (APN) is a global program focused on helping companies build successful AWS-based businesses or solutions by providing business, technical, marketing, and go-to-market support. The APN includes independent software vendors (ISVs) and systems integrators (Sis) worldwide, with AWS Partner participation growing significantly during the past 12 months.

“AWS Partners are at the center of unlocking value for global customers across a wide range of industries,” said Ruba Borno, Vice President, Worldwide Channels and Alliances at AWS. “We are honored to launch the inaugural global 2022 AWS Partner Awards and thank all the nominees and winners for accelerating our customers’ cloud transformation journey.”

A panel of AWS experts selected the winners based on strict criteria. Quantiphi received Machine Learning/Artificial Intelligence (AI/ML) Partner of the Year in North America.  This award recognized top AWS Partners with Machine Learning Competency who have demonstrated machine learning expertise. Quantiphi was also awarded Industry Partner of the Year in North America, recognizing AWS Partners with deep domain expertise in a specific industry vertical that solves customer pain points or supports their customers in new offerings. Quantiphi helps global financial services firms derive value from cloud-based architectures, big data analytics, and AI by leveraging AWS products and services.

landis+gyr-to-launch-smart-water-meter-and-showcase-latest-grid-edge-and-ev-charging-solutions-at-enlit-europe

Landis+Gyr to Launch Smart Water Meter and Showcase Latest Grid Edge and EV Charging Solutions at Enlit Europe

November 29, 2022 Published by

 

Showcasing its expanded portfolio in Smart Metering, Grid Edge Intelligence and Smart Infrastructure, Landis+Gyr (SIX: LAND) will exhibit the latest hardware and software solutions for electricity, heat, gas and water metering. In addition, the company introduces stations and tools for energy-efficient EV charging.

The company launches its latest addition of ultrasonic smart water meters, W270 and W370, based on IoT technologies. In line with the Landis+Gyr Green Design principles, the new portfolio is 100% recyclable after its extensive lifetime of more than 15 years. In order to deliver valuable information for smart water networks, the meter provides not only data in terms of volume, but also additional information like water temperatures, statistical values, alarms and events. Equipped with modern IoT communication like NB-IoT, the meter is fully integrated into latest generation communication networks, enabling remote control.

In addition, Landis+Gyr showcases its interactive electric vehicle charging line, INCH Pro and INCH Duo which enable the best user experience and reduce operating costs, dynamically balancing charging power for more energy-efficient charging. Accepting digital signals through the power lines and frequency monitoring make INCH chargers capable of autonomously responding to grid conditions – managing the charging power and impact on the electric grid. Furthermore, the OCEAN software, a scalable and remote EV charge point and energy management software, performs advance load management tasks to support demand response and load flexibility services.

Since the launch of Gridstream® Connect, its secure and scalable IoT platform in 2019, Landis+Gyr has been upgrading its suite of smart meters with new variants for residential, industrial and grid measurement needs. Having launched two variants of the E360 residential meters and the second generation of the E660 industrial meter earlier in 2022, Landis+Gyr will round off the year with the launch of the E860 grid meter and the power quality cloud SaaS solution for grid edge intelligence. With ten times the accuracy and speed of modern meters and an extensible modular architecture, the new generation of IoT-ready smart meters by Landis+Gyr offers advanced grid edge intelligence to support DSOs in maintaining a safe, reliable and efficient grid.

“Managing energy consumption with more efficiency has never been more crucial than today”, said Werner Lieberherr, Chief Executive Officer of Landis+Gyr. “If the current energy crisis and the urgent need for global decarbonization have taught us one thing, it’s that resources are finite and having the insights and tools to shape the way they’re used is key.” Bodo Zeug, Executive Vice President of EMEA at Landis+Gyr added: “Utilities require fast, reliable, and secure data transmission. We’re excited to showcase our abilities to collect, monitor and process data at the grid edge at Enlit Europe, providing solutions to balance load and ensure continued power quality and reliability.”

During the conference, Landis+Gyr leaders and experts will host sessions about the role of the future grid and the EV disruption:

  • Interview with Werner Lieberherr, CEO of Landis+Gyr
    Summit: Interview, November 29, 16:40 – 16:55, Afternoon Session, Connect Studio (Hall 11.1)
  • “How to ensure grid resilience in the new energy era” by Ifigeneia Stefanidou, Head of Grid Edge Product Management at Landis+Gyr
    Grid Edge technologies: Utilities at work, November 30, 11:15 – 11:30, Digitalization Hub 4 (Hall 12.0)
  • “EV disruption for more efficient, safer and cleaner grid” by Rok Kobal, Head of Hardware Sales at Etrel – a Landis+Gyr company
    Decentralization | EV for the Grid, November 30, 15:30 – 15:45, Decentralization Hub 1 (Hall 12.0)

To learn more about Landis+Gyr’s energy management portfolio, join us at Enlit Europe in Frankfurt from November 29th to December 1st in Hall 12.1, Booth D40 or visit www.landisgyr.eu/enlit-europe-2022 for more information.

kx-supports-b2c2-for-trading-analytics,-driving-further-innovation-in-the-digital-assets-space

KX Supports B2C2 for Trading Analytics, Driving Further Innovation In the Digital Assets Space

November 29, 2022 Published by

 

KX, maker of kdb+, the world’s fastest time series database and analytics engine, announces that B2C2, the world’s leading crypto liquidity provider and a digital asset pioneer, has expanded its use of KX’s real-time high-performance analytics software, including the deployment of KX Dashboards, its powerful visualization tool. As more institutional firms enter the world of cryptocurrencies, the increased use of KX will enable B2C2 to offer clients tailored products and services at a level that is more akin to what is found at a tier-one investment bank.

KX – which built its technology in the most demanding data environments of capital markets – provides B2C2 with a robust, high-velocity real-time analytics platform, and powerful dashboards for rich data visualization, business intelligence, and reporting capabilities that adapt seamlessly to the needs of digital markets. With kdb+ at its core, the KX analytics technology stack gives B2C2 the capability to process and analyze enormous amounts of data, both time series and relational, at speed and scale for richer actionable intelligence, and critical split-second decision-making.

The adoption of KX Dashboards, the interactive and robust visualization tool for kdb+, follows a thorough evaluation process from B2C2, which is utilizing it across the firm.

Nicola White, Group CEO B2C2: “We are pleased to be working with KX, which supports B2C2 in delivering real-time data-driven trading insights and decisions to digital assets markets. KX is recognized and respected for its industry-leading technology across the world’s major financial institutions and working with them aligns with our clients’ and counterparties’ capabilities.”

James Corcoran, Chief Growth Officer, KX: “We’re delighted to be further strengthening our long-standing relationship with B2C2 by supporting its continued innovation and growth in the digital assets space. KX technology is proven in enhancing a broad range of mission-critical data and trading systems across front, middle and back-office operations for the majority of the world’s leading tier-one banks, brokerages, and investment firms. Our services have extended to other major participants in the global financial ecosystem, including the crypto markets. Together we can continue to drive innovation across the expanded financial services sector.”

B2C2’s success is built on crypto-native technology, sophisticated systematic market making, and risk management, as well as continuous product innovation. It is a recognized leader in the digital assets sector and provides reliable liquidity across multiple market conditions, enabling a broad range of investors, including larger institutions such as investment banks and hedge funds, to gain access to cryptocurrencies and derivatives products.

Built for the modern data ecosystem, KX technology can ingest, store, manage and analyze, time series data and relational data at enormous speed and scale no matter where it sits across an organization.  Its robust visualization dashboards and extensive integration with 3rd party business intelligence tools enable users to make faster, better informed in-the-moment decisions, delivering rapid ROI and measurable business value. A recent Forrester Consulting Total Economic Impact Study found that customers could achieve 315% return on investment (ROI) and less than 6 months’ payback on implementing KX.

natural-killer-(nk)-cell-therapeutics-market-to-perceive-healthy-cagr-of-40.9%-by-2029,-size,-share,-trends,-demand,-opportunities,-challenges-and-competitive-analysis

Natural Killer (NK) Cell Therapeutics Market to Perceive Healthy CAGR of 40.9% by 2029, Size, Share, Trends, Demand, Opportunities, Challenges and Competitive Analysis

November 28, 2022 Published by

 

Data Bridge Market Research completed a qualitative study titled “Natural Killer (NK) Cell Therapeutics Market” with 100+ market data tables, pie charts, graphs, and figures spread across Pages and an easy to grasp full analysis. By keeping into focus customer requirements, an influential Natural Killer (NK) Cell Therapeutics market analysis report has been generated by chewing over quite a lot of market parameters. These factors consist of but are not limited to latest trends, market segmentation, new market entry, industry forecasting, future directions, opportunity identification, strategic analysis and planning, target market analysis, insights and innovation. For market segmentation study conducted in the large scale Natural Killer (NK) Cell Therapeutics report, the market of potential customers is divided into groups or segments based on different characteristics such as application of product, deployment model, end user and geographical region etc.

Global natural killer (NK) cell therapeutics market is supportive and aims to reduce the progression of the disease. Data Bridge Market Research analyses that global natural killer (NK) cell therapeutics market will grow at a CAGR of 40.9% during the forecast period of 2022 to 2029.

Download Sample Copy of Natural Killer (NK) Cell Therapeutics Market Report @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-natural-killer-nk-cell-therapeutics-market

Market Overview:

Natural killer (NK) cells therapeutics report provides details of market share, new developments, and product pipeline analysis, the impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market. Contact us for an analyst brief to understand the analysis and the market scenario; our team will help you create a revenue impact solution to achieve your desired goal. An increase in the usage of natural killer cells for the treatment of infectious diseases is the major driver that propelled the market’s demand in the forecast period.

Global natural killer (NK) cell therapeutics comprises features such as an increasing need for better therapeutics options that will impair the manufacturers’ launching new products into the market, enhancing its increased demand investment in research and development leads to the market growth. Currently, various research studies are taking place, which is expected to create a competitive advantage for manufacturers to develop new and innovative natural killer (NK) cell therapeutics that will provide various other opportunities in the natural killer (NK) cells therapeutics market. However, adverse side effects of therapies and unfavorable & inadequate reimbursement scenarios are expected to restrain the market growth in the forecast period.

Opportunities for Players:

  • Strategic Initiatives by Market Players

Market players adopt various strategic initiatives that involve expansion, acquisition, and collaboration, among others. These initiatives help them increase the company’s product portfolio, leading to market expansion and, hence, enhancing the product demand among customers, ultimately leading the players to earn maximum revenue.

As the demand for effective and affordable natural killer (NK) cell immunotherapy is increasing worldwide, these strategic initiatives are taken by top market players aimed at enhancing business operations and earning more profitability in the market.

Some of the major players operating in the Natural Killer (NK) Cell Therapeutics market are:

  • Merck KGaA,
  • Bristol-Myers Squibb Company,
  • Glycostem,
  • Kiadis Pharma,
  • Cytovia Therapeutics,
  • Nkarta, Inc.,
  • Nektar,
  • ImmunityBio, Inc.,
  • Brink Biologics, Inc.,
  • Biohaven Pharmaceuticals,
  • Fate Therapeutics,
  • EMERcell,
  • Phio Pharmaceuticals,
  • PersonGen BioTherapeutics,
  • Innate Pharma, Inc.,
  • INmuneBIO,
  • Gamida Cell,
  • Acepodia Inc.,
  • Affimed GmbH,
  • Multimmune GmbH,
  • iCell Gene Therapeutics,
  • Takeda Pharmaceutical Company Limited,
  • Regeneron Pharmaceuticals

Get Full Research Report to Understand More @ https://www.databridgemarketresearch.com/checkout/buy/enterprise/global-natural-killer-nk-cell-therapeutics-market

Recent Developments

  • In January 2022, Takeda to Acquire Adaptate Biotherapeutics to Develop Novel Gamma Delta (γδ) T Cell Engager Therapies Targeting Solid Tumors.  Through the acquisition, Takeda will obtain Adaptate’s antibody-based γδ T cell engager platform, including pre-clinical candidate and discovery pipeline programs. Adaptate’s γδ T cell engagers are designed to specifically modulate γδ T cell-mediated immune responses at tumor sites while sparing damage to healthy cells. This acquisition help the company to to focus on R&D.
  • In December 2021, Nektar Therapeutics announced phase 1b data for novel T regulatory cell stimulator NKTR-358 (LY3471851) in patients with atopic dermatitis. NKTR-358 is designed to treat autoimmune and inflammatory conditions by correcting the immune system imbalance that results from increased levels of inflammatory T cells and reduced numbers and impaired function of immune regulating Treg cells. This has helped company to focus on R&D for further phases.

The report provides insights on the following pointers:

Market Penetration: Comprehensive information on the product portfolios of the top players in the Natural Killer (NK) Cell Therapeutics market

Product Development/Innovation: Detailed insights on upcoming technologies, R&D activities, and product launches in the market

Competitive Assessment: In-depth assessment of the market strategies, and geographic and business segments of the leading players in the market

Market Development: Comprehensive information about emerging markets. This report analyzes the market for various segments across geographies

Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the Natural Killer (NK) Cell Therapeutics Market

THANKSGIVING WEEK SALE!!!

Get UP TO 35%. OFF ON GLOBAL REPORTS. OFFER VALID TILL 30th NOV 2022

For More, Inquire at https://www.databridgemarketresearch.com/inquire-before-buying/?dbmr=global-natural-killer-nk-cell-therapeutics-market

Market Dynamics: Natural Killer (NK) Cell Therapeutics Market

  • Increase in Patient Population with Chronic Diseases

Chronic diseases generally occur in older adults that can be controlled but not cured, such as heart disease, arthritis, diabetes, stroke, or cancer. Chronic diseases are a worldwide healthcare problem concern. The change in lifestyle and physical inactivity, unhealthy diet, and tobacco use increase the burden of chronic diseases worldwide.

An increasing number of the patient population with the chronic disease led the scientist and researchers to work upon the new innovative therapeutic approach to provide patients with the best curative treatment option, which can be achieved by using natural killer (NK) cell therapy that has the potential to generate a strong immune response and has the anti-tumor capability as well.

  • Rise in Awareness about Immunotherapies

As cancer is a devastating disease and available treatment options may cause the reoccurrence of tumors, the need for the best therapeutic approach is increasing day by day. Immunotherapies have attracted much attention in recent years to treat various malignancies. Among the immunotherapies, CAR –T cell therapies have been studied and were used but have several limitations that led to the development of natural killer (NK) cell therapies. As a drug based on the natural killer (NK) cell therapeutic approach has not been approved yet, it thus needs to raise awareness among the population.

This is why several organizations and market players are launching a campaign to enhance natural killer (NK) cell therapies awareness.

Consider Data Bridge Market Research for this Report which would Help Impact Your Revenues Positively

  • This study offers the latest product news, trends, and updates from the industry’s leading players who have leveraged their market position.
  • It also offers strategic plans and standards to arrive at informed business decisions adopted by the main players, thereby advocating your go to market strategies.
  • In addition, it offers insights into the dynamics of customer behaviour that can help the organization better curate market strategies
  • Usage of exclusive tailor-made tools along with primary research, secondary research and our in-house data model helps us in extracting the exact market numbers
  • Mapping the customer in 3P grid comprising of Purpose, Planning and Positioning, thereby delivering a solution by keeping the prospecting client at the sweet spot
  • The Natural Killer (NK) Cell Therapeutics market research report includes all of the market’s valuable elements, such as sales growth, product pricing & analysis, growth opportunities, and recommendations for addressing market challenges
  • The report covers all the primary mergers & acquisitions, alliances, and collaborations that have generated additional opportunities for market players or in some cases, challenges

To Gain More Insights about this Research, Visit @ https://www.databridgemarketresearch.com/reports/global-natural-killer-nk-cell-therapeutics-market

Key Industry Segmentation: Natural Killer (NK) Cell Therapeutics Market

By Therapeutics

  • NK Cell Therapies
  • NK Cell Directed Antibodies

By Approaches

  • Antibody-Dependent Cell-Mediated Cytotoxicity (ADCC)
  • Bispecific Antibodies

By Application

By End User

  • Research & Academic Institutes
  • Hospitals
  • Specialty Clinics

By Distribution Channel

  • Hospital Pharmacies
  • Direct Tender

Regional Analysis/Insights: Natural Killer (NK) Cell Therapeutics Market

The countries covered in the natural killer (NK) cell therapeutics market report are U.S., Canada, Mexico, Germany, France, Italy, U.K., Spain, Netherlands, Russia, Switzerland, Turkey, Austria, Norway, Hungary, Lithuania, Ireland, Poland, Luxembourg , Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific , Brazil, Argentina, Peru, Rest of South America, Saudi Arabia, South Africa, UAE, Israel, Kuwait, Egypt, Rest of Middle East & Africa.

Asia-Pacific is expected to dominate due to increase in usage of natural killer (NK) cells for the treatment of cancer and infectious diseases.

Table of Contents:

  1. Introduction
  2. Market Segmentation
  3. Executive Summary
  4. Premium Insights
  5. Global Natural Killer (NK) Cell Therapeutics Market: Regulations
  6. Market Overview
  7. Global Natural Killer (NK) Cell Therapeutics Market, By Therapeutics
  8. Global Natural Killer (NK) Cell Therapeutics Market, By Approaches
  9. Global Natural Killer (NK) Cell Therapeutics Market, By Application
  10. Global Natural Killer (NK) Cell Therapeutics Market, By End User
  11. Global Natural Killer (NK) Cell Therapeutics Market, By Distribution Channel
  12. Global Natural Killer (NK) Cell Therapeutics Market, By Region
  13. Global Natural Killer (NK) Cell Therapeutics Market: Company Landscape
  14. SWOT Analyses
  15. Company Profile
  16. Questionnaires
  17. Related Reports

To Check the Complete Table of contents, click here @ https://www.databridgemarketresearch.com/toc/?dbmr=global-natural-killer-nk-cell-therapeutics-market

Explore More Reports:

Europe Natural Killer (NK) Cell Therapeutics Market, By Therapeutics (NK Cell Therapies, NK Cell Directed Antibodies), Approaches (Antibody-Dependent Cell-Mediated Cytotoxicity (ADCC), Bispecific Antibodies), Application (Cancer, Immunoproliferative Disorders, Acute Infectious Diseases, Gastrointestinal Diseases, Others), End User (Research & Academic Institutes, Hospitals, Specialty Clinics), Distribution Channel (Hospital Pharmacies, Direct Tender, Others) https://www.databridgemarketresearch.com/reports/europe-natural-killer-nk-cell-therapeutics-market

North America Natural Killer (NK) Cell Therapeutics Market, By Therapeutics (NK Cell Therapies, NK Cell Directed Antibodies), Approaches (Antibody-Dependent Cell-Mediated Cytotoxicity (ADCC), Bispecific Antibodies), Application (Cancer, Immunoproliferative Disorders, Acute Infectious Diseases, Gastrointestinal Diseases, Others), End User (Research & Academic Institutes, Hospitals, Specialty Clinics), Distribution Channel (Hospital Pharmacies, Direct Tender, Others) https://www.databridgemarketresearch.com/reports/north-america-natural-killer-nk-cell-therapeutics-market

Asia-Pacific Natural Killer (NK) Cell Therapeutics Market, By Therapeutics (NK Cell Therapies, NK Cell Directed Antibodies), Approaches (Antibody-Dependent Cell-Mediated Cytotoxicity (ADCC), Bispecific Antibodies), Application (Cancer, Immunoproliferative Disorders, Acute Infectious Diseases, Gastrointestinal Diseases, Others), End User (Research & Academic Institutes, Hospitals, Specialty Clinics), Distribution Channel (Hospital Pharmacies, Direct Tender, Others) https://www.databridgemarketresearch.com/reports/asia-pacific-natural-killer-nk-cell-therapeutics-market

Middle East and Africa Natural Killer (NK) Cell Therapeutics Market, By Therapeutics (NK Cell Therapies, NK Cell Directed Antibodies), Approaches (Antibody-Dependent Cell-Mediated Cytotoxicity (ADCC), Bispecific Antibodies), Application (Cancer, Immunoproliferative Disorders, Acute Infectious Diseases, Gastrointestinal Diseases, Others), End User (Research & Academic Institutes, Hospitals, Specialty Clinics), Distribution Channel (Hospital Pharmacies, Direct Tender, Others) https://www.databridgemarketresearch.com/reports/middle-east-and-africa-natural-killer-nk-cell-therapeutics-market

Health Tourism Market, By Service (Transport, Accommodation, Hospitality and Others), Type of Treatment (Cosmetic Treatment, Dental Treatment, Cardiovascular Treatment, Orthopaedic Treatment, Bariatric Treatment, Fertility Treatment, Cancer Treatment, Ophthalmic Treatment, Neurological Treatment and Others), Age Group (Senior Citizens, Minors and Adults), By Service Provider (Private and Public) https://www.databridgemarketresearch.com/reports/global-health-tourism-market

Nanomedicine Market, By Product Type (Nano Molecules, Nanoparticles, Liposomes, Polymer And Polymer Drug Conjugates, Hydrogel Nanoparticles, Dendrimers, Nanoshells, Nanotubes And Nanodevices), Application (Vaccines, Regenerative Medicines, Diagnostic Imaging, Drug Delivery, Implants, In-Vitro Imaging, In-Vitro Diagnostics, Therapeutics And Others), Indication (Oncological Diseases, Infectious Diseases, Cardiovascular Diseases, Orthopedic Disorders, Neurological Disorders, Urological Disorders, Ophthalmological Diseases, Immunological Diseases, Anti-Inflammatory Diseases, Anti-Infective Diseases And Others) Modality (Treatments And Diagnostics), And Country https://www.databridgemarketresearch.com/reports/global-nanomedicine-market

eHealth Market, By Offering (Solutions and Services), Deployment (Cloud and On-Premises), Enterprise Size (Large Enterprises and Small and Medium Enterprises), Functionality (Content Management System, Group Messaging, Dashboard, Video Sessions, Social Support, and Others), Technology (Internet of Things (IoT), Chatbots, Artificial Intelligence, Block Chain and Big Data, and Others), End User (Healthcare Providers, Payers, Healthcare Consumers, Pharmacies, and Others) https://www.databridgemarketresearch.com/reports/global-ehealth-market

Healthcare Information Technology (IT) Market, By Product and Services (Healthcare Provider Solutions, Healthcare Payer Solutions, Healthcare Information Technology Outsourcing Services), Components (Services, Software, Hardware), Delivery Mode (On-Premise, Cloud-Based), End-Users (Providers, Payers) https://www.databridgemarketresearch.com/reports/global-healthcare-it-market

Diabetes Care Devices Market, By Product (Blood Glucose Monitoring Device, Insulin Delivery Devices), End User (Point of Care, Home Diagnostics, Research Labs, Hospital and Clinics), Country https://www.databridgemarketresearch.com/reports/global-diabetes-care-devices-market

yidu-tech-announces-results-for-the-first-half-of-fy2023:-adjusted-net-loss-narrowed-down-30.3%-yoy,-strategic-focus-enhanced-business-resilience

Yidu Tech Announces Results for the First Half of FY2023: Adjusted Net Loss Narrowed down 30.3% YoY, Strategic Focus Enhanced Business Resilience

November 28, 2022 Published by

 

Yidu Tech Inc. (“Yidu Tech” or “the Company”, together with its subsidiaries and consolidated affiliated entities, “the Group”, HKEx: 2158), a leading corporate in China’s healthcare intelligence industry, announced the interim results for the six months ended 30 September 2022 (“the first half of FY2023” or “the Reporting Period”).

Despite the challenging and uncertain external environment, the Group remained committed to improving profitability with a strategic focus. The Group continues to focus on applying digital and intelligent applications to multiple use-case scenarios, concentrating on key disease research areas such as solid tumors, hematology, ophthalmology and immunology to further strengthen its core competence, improve customer experience and increase customers’ average transaction value. During the Reporting Period, the Group reported a total revenue of RMB474.4 million and adjusted net loss narrowed to RMB224.8 million, a decrease of 30.3% year-on-year. Total operating expense as a percentage of revenue decreased by 32.1 percentage points.

Ms. Gong Yingying (Rujing), Chairlady and Founder, Executive Director and Chief Executive Officer of Yidu Tech, stated, “The Group has taken proactive and effective measures to enhance operational efficiency and has successfully narrowed its loss and adjusted net loss significantly during the Reporting Period, which is a testament to the effectiveness of our business development strategy. We expect a continued improvement in operation efficiency going forward, and we will continue to make progress toward achieving profitability. Yidu Tech will adhere to its original vision of ‘green healthcare’, continue to enhance its core technology capabilities, and deepen its efforts in the three scenario categories of research, diagnosis and treatment, and public health, in order to create more value in the healthcare intelligence industry.”

Deep cultivation of three major scenarios with strategic focus on aiding commercialization

During the Reporting Period, Yidu Tech proactively enhanced its profitability with a strategic focus on four major areas: business, customers, diseases and organization.

In terms of business, Yidu Tech continues to focus on scenarios in three major categories, namely research, diagnosis and treatment, and public health. The Company promotes multi-scenario applications based on the three categories, achieving scenario-driven optimization of intelligence. Driven by innovation, the Group continuously upgrades its portfolio of high-quality professional products and services to meet the diverse demands of its core customers.

In terms of customers, Yidu Tech focuses on serving core hospitals and core pharmaceutical companies with high revenue retention. In the Big Data Platform and Solutions (“BDPS”) segment, the Company upgraded and launched the All Disease Data Platform, which facilitates the DIY creation of disease registries by hospitals. In addition, in the Life Science Solutions (“LSS”) segment, the revenue retention rate for the top 10 clients reached 119%.

In terms of diseases, during the Reporting Period, the Group concentrated on key disease research areas including solid tumors, hematology, ophthalmology and immunology. Regarding organization, based on the intelligent “medical brain” YiduCore and the overlapping applications of its core capabilities, Yidu Tech continued to enhance the synergy among the three business segments and to increase customer awareness. Meanwhile, the Group continuously improved the business penetration and internal operating efficiency, and continued to reduce the ratio of total operating expense to revenue during the Reporting Period, which was brought down by 32.1 percentage points year-on-year.

Continuous Technological Innovation to Drive the Development of the Healthcare Intelligence Ecosystem

Guided by the national strategy of high-quality development driven by innovation, the “14th Five-Year Plan” and the “Healthy China 2030” policy, China has put in place series of policies to encourage scenario-driven proprietary innovation. As a leading corporate in the healthcare intelligence industry, Yidu Tech has continuously improved its capabilities in independent R&D and innovation, focusing on solving the pain points faced by the healthcare industry as it undergoes an intelligent transformation.

Over the years, Yidu Tech has independently developed YiduCore which consists of algorithms and insightful medical knowledge that are continuously accumulated and constantly iterated as the Group expands its use-case scenarios with proper authorization. In the first half of FY2023, Yidu Tech continued to invest resources in cooperation with renowned hospitals and experts, to continue empowering its ability to build and enrich a disease labelling system that encompasses various fields of diseases. As of 30 September 2022, YiduCore’s medical knowledge graph covers over 80,000 medical objects, of which the number of diseases covered by the disease knowledge graph has exceeded 10,000, an increase of over 1,000 compared to six months earlier.

With YiduCore’s strong data processing capabilities and AI algorithms, as well as its accumulated medical knowledge, insights and disease models, Yidu Tech has undertaken a total of 19 scientific research projects with its partners, including renowned hospitals, regulators and universities, of which 8 are national-level research projects sponsored by the Ministry of Science and Technology of China and other national ministries. As of 30 September 2022, the effectiveness and accuracy of its pandemic response and prediction algorithms have been validated in 22 cities.

In terms of privacy protection, the Company participated in the preparation of the Research Report on the Application of Privacy Computing (2022) issued by the Institute of Cloud Computing and Big Data of the China Academy of Information and Communication Technology (CAICT). In addition, by virtue of its outstanding remote operation and maintenance technology, Yidu Tech obtained the Certificate of Remote Operation and Maintenance Safety Capability Inspection issued by the Internet Health Care Industry Alliance and CAICT.

Balanced development of three business segments, demonstrating strong business resilience

During the Reporting Period, the revenue of all three business segments maintained a balanced development, demonstrating strong business resilience.

The Big Data Platform and Solutions segment generated revenues of RMB 124.0 million during the Period. One aspect of this segment is Yidu Tech’s provision of AI-based intelligence platforms and data analytics-driven solutions to regulators and policy makers. During the Reporting Period, the Group led a consortium and won the contract for the Infectious Disease Intelligent Multi-point Surveillance Early Warning Platform for Beijing. With AI-empowered analytical tools and top-notch simulation models, the Group has expanded its solution offerings from public health to population health. During the Reporting Period, the Group won the construction of regional healthcare profiling for local residents in Chaoyang District, Beijing.

The other aspect of this segment is the Group’s continued effort to deepen its insight into diseases. In the field of hematology, the Group has partnered with two of China’s only three hematologic diseases National Clinical Research Center (NCRC) hospitals in developing a hematologic disease research network to conduct efficient clinical trials and multi-institutional real-world studies. Meanwhile, the Group has assisted its clients to develop a number of disease registries and large clinical research cohorts for major hematological diseases, including leukemia, coagulation disorders and aplastic anemia. With the successful precedented cases in hematology, the Group made breakthroughs in the field of dermatology by winning the contract with Institute of Dermatology, Chinese Academy of Medical Sciences, one of China’s top two hospitals in the field of dermatology, to build a disease research platform.

The Life Science Solutions segment achieved revenue of RMB 146.5 million during the Reporting Period. With accumulated credentials in focused disease research areas, as of 30 September 2022, Yidu Tech has performed 232 clinical research trials, including clinical trials sponsored by pharmaceutical companies and investigator-initiated trials (IIT). The Group has performed 185 prospective and retrospective real-world studies. Its Intelligent Site Management Organization (iSMO) services have covered 163 sites, more than doubling the number from last year. It is worth noting that, during the Reporting Period, the Group conducted a comprehensive retrospective real-world study which related to the evaluation of the efficacy, safety and treatment modalities of a new drug for patients with complex abdominal infections in ICU for a top 20 multi-national pharmaceutical companies (MNC) client to assist it to obtain the approval from the Center for Drug Evaluation, National Medical Products Administration (CDE).

The growing track records has enabled the Group to continuously develop the LSS segment and maintain its high-quality customer base. As of 30 September 2022, there were 143 active clients. Among its top 20 clients, there were 7 MNC and 16 listed companies.

The revenue of the Group’s Health Management Platform and Solutions segment amounted to RMB 203.8 million. Leveraging medical insights powered by YiduCore and AI empowerment, Yidu Tech facilitated its customers’ ability to design and develop innovative insurance products, enabling faster and more accurate insurance underwriting and expediting claim processing. During the Reporting Period, the Group continued to increase the market penetration of the Hui Min Bao business, serving 3 provinces and 10 cities. Yidu Tech has assisted three of the four municipalities directly under the central government in China to launch Hui Min Bao products, including Tianjin, Beijing and Chongqing. As of 30 September 2022, the number of active users who have completed at least one transaction on Yidu Tech’s health management platform reached 15 million.

Furthermore, the Group’s advanced intelligence technologies greatly improve the operating efficiency of Hui Min Bao. As the main operating platform for Jiangsu Hui Min Bao, the Group underwrote more than 3 million Jiangsu Hui Min Bao policies and approximately 76% of total claim amounts were completed by the Group’s intelligent claim settlement services. Compared with traditional methods, the Group’s intelligent claim settlement services tripled the productivity of processing claims, reducing the financial burden of the insured and further encouraging participation.

As the market leader with the largest market share in the healthcare intelligence market, the medical institutions and regulatory agencies healthcare intelligence market as well as the emerging healthcare intelligence market in China, Yidu Tech is committed to contributing to the intelligent transformation and upgrading of the healthcare industry, as well as the high-quality development of the healthcare industry. In the future, Yidu Tech will continue to adhere to its two-pronged strategy, expand its infrastructure network, deepen its research into diseases, maintain its strategic focus on business, customers, diseases and organization, and contribute to creating the healthcare intelligence ecosystem, upholding its mission to make value-based precision healthcare accessible to everyone and create more value for healthcare industry participants.

Latest Members

Recent AchievementsYou must be logged in to view earned achievements

What is a Wire Coin?

Find connections

Who is online

Latest Hashtags

#artificialintelligence #betting #blockchain #casino #esports #fintech #gaming #hiptherfestival #hipthers #igaming #slots #technology